SARMs merchant accounts UK
SARMs sit in the same processing tier as research peptides and mainstream UK acquirers decline them on category. Card schemes treat SARMs as unlicensed-medicine and research-chemical risk, and Stripe, PayPal, SumUp, Square and the high-street acquirers reject or terminate on review. Specialist research-chemical acquirers underwrite SARMs on a case-by-case basis at elevated rates and reserves, with close scrutiny of how the product is presented. The legal exposure rises sharply the moment a page implies human use.
Legal status (UK)
Sold lawfully in the UK only as research chemicals labelled not for human consumption. SARMs are not approved for human use and marketing them for bodybuilding, dosing or consumption makes them unlicensed medicines under MHRA enforcement.
Best way to take SARMs payments (UK)
Our pick
MerchantHQ: a specialist SARMs quote through our broker partner
Mainstream UK acquirers (SumUp, Square, Zettle, Dojo, Worldpay, Barclaycard) decline SARMs businesses at onboarding or terminate after launch. Our broker partner works with specialist high-risk acquirers that underwrite it, and works to return 2 to 3 matched quotes for your licence, volume and processing history.
Our broker partner pays us a fee for each introduction, so it costs you nothing on top, and we never sell your details on. Your risk classification travels with the enquiry, so specialist providers are approached from the start.
Get matched to a SARMs acquirerHigh-risk merchants are the most exposed to chargebacks, frozen funds and MATCH/TMF listings. Once you are live your provider runs the account; our free guides cover chargebacks, reserves and frozen funds and MATCH/TMF listings.
How SARMs placements work
SARMs routes to specialist regulated-vertical acquirers matched per application rather than a published list. The right underwriter depends on your licence, volume and sub-category, so our broker partner approaches it individually, disclosing your risk classification upfront so the right acquirer is contacted from the start.
Typical pricing
- Rate
- 3.5% to 6.0% blended
- Settlement reserve
- 10% to 20% rolling reserve common
Indicative ranges based on typical UK high-risk acquirer pricing for this category. Your actual rate and reserve are set per merchant at underwriting and will differ.
Watch outs
- Labelling must state research-use-only, not for human consumption; any bodybuilding, dosing or cycle guidance reclassifies the product as an unlicensed medicine.
- No performance, muscle-gain or health claims in copy, metadata or advertising.
- Mainstream processors terminate SARMs accounts on detection; a compliant specialist account avoids frozen funds.
- Underwriting reviews COA documentation, age-gating and disclaimer placement.
Common questions
Why do mainstream acquirers decline SARMs businesses?
Mainstream UK acquirers (SumUp, Square, Zettle, Dojo, Worldpay, Barclaycard) set risk policies for their typical merchant base, and SARMs usually falls outside it on chargeback rate, regulatory exposure or reputational risk. That is a policy fit issue, not a reflection of your business. Specialist high-risk acquirers price for and underwrite this risk directly, which is why they work with SARMs where mainstream providers will not.
Does a high-risk merchant account cost more?
Usually, yes. Expect a higher transaction rate and a settlement reserve (a percentage of takings held back for a rolling period) rather than same-day or next-day settlement. That is the trade-off for a specialist underwriter taking on chargeback and regulatory risk a mainstream acquirer will not price for at all.
How long does approval take for a high-risk merchant account?
Typically longer than a mainstream application, because the underwriter reviews your licensing, processing history and risk controls individually rather than running an automated check. Bringing a clean processing history, current licensing documents and realistic volume projections to the first application materially speeds this up.
Can I switch to a mainstream acquirer once I am established?
Sometimes, once you have a settled processing history and the underlying risk profile has genuinely reduced, but never guaranteed. Some verticals stay classified as high-risk regardless of trading history because the classification is about the category, not just the individual merchant's record.
Is MerchantHQ a lender or the acquirer?
Neither. MerchantHQ is a comparison and introducer service. Your quote enquiry goes to our card-payments broker partner, Merchant Advice Service (peptide businesses go to Fena instead), which works to return 2 to 3 matched quotes from providers that take your kind of business. The broker pays us a fee for each introduction, so there is no cost to you. The acquirer you choose processes your payments.
Related
See the full high-risk merchant guide, how merchant accounts work, compare card terminals, or check card machine costs.
Founder & Managing Director, Muswell Rose, founder and PSC of Best Business Loans Ltd
Adam is the founder and managing director of Muswell Rose and a founder of Best Business Loans Ltd, the company behind MerchantHQ. His career runs through insurance, mortgages, commercial finance and fintech lending, including payments and merchant services. He writes the MerchantHQ library.
Last updated:
Payments review: Derren Powell, payments and fintech specialist, formerly Vice President, Business Development (Merchants) at Mastercard. Independent reviewer; the MerchantHQ editorial team retains control of the final content.